Palo Alto Investors LLC 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:02 pm Sale |
2024-09-30 | 13G | Revance Therapeutics, Inc. RVNC |
Palo Alto Investors LLC | 1,611,787 1.540% |
-3,625,497 (-69.22%) |
Filing |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Palo Alto Investors LLC | 5,237,284 5.960% |
-46,325 (-0.88%) |
Filing |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Palo Alto Investors LLC | 5,283,609 6.420% |
914,243 (+20.92%) |
Filing |
| 2022-02-14 5:04 pm Purchase |
2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Palo Alto Investors LLC | 4,369,366 6.090% |
4,369,366 (New Position) |
Filing |